0001209191-19-012249.txt : 20190221
0001209191-19-012249.hdr.sgml : 20190221
20190221180708
ACCESSION NUMBER: 0001209191-19-012249
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190219
FILED AS OF DATE: 20190221
DATE AS OF CHANGE: 20190221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smither John W
CENTRAL INDEX KEY: 0001559583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38653
FILM NUMBER: 19623293
MAIL ADDRESS:
STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC.
STREET 2: 27200 WEST AGOURA ROAD, SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Principia Biopharma Inc.
CENTRAL INDEX KEY: 0001510487
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263487603
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 302
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 416-7700
MAIL ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 302
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-19
0
0001510487
Principia Biopharma Inc.
PRNB
0001559583
Smither John W
C/O PRINCIPIA BIOPHARMA INC.
220 E. GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Director Stock Option (right to buy)
30.30
2019-02-19
4
A
0
20475
0.00
A
2029-02-18
Common Stock
20475
20475
D
The stock option vests in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
/s/ Christopher Y. Chai, Attorney-in-Fact for John W. Smither
2019-02-21